Novel strategies to fight Candida species infection

References

• Abdullah K, Soliman M, Mohamed M. (2013). Susceptibility of Candida albicans clinical isolates to some plant extracts in Saudi Arabia. ZUMJ 19:294–9
   Google Scholar
• Agarwal V, Lal P, Pruthi V. (2010). Effect of plant oils on Candida albicans. J Microbiol Immunol Infect 43:447–51
   PubMedGoogle Scholar
• Almirante B, Rodriguez D, Cuenca-Estrella M, et al. (2006). Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 44:1681–5
   PubMed Web of Science ®Google Scholar
• Alves C, Ferreira I, Barros L, et al. (2014). Antifungal activity of phenolic compounds identified in flowers from the North Eastern Portugal against Candida species biofilms. Future Microbiol 9:139–46
   PubMed Web of Science ®Google Scholar
• Andes D. (2003). In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrob Agents Chemother 47:1179–86
   PubMed Web of Science ®Google Scholar
• Anibal PC, Sardi JDCO, Peixoto ITA, et al. (2010). Conventional and alternative antifungal therapies to oral candidiasis. Braz J Microbiol 41:824–31
   PubMed Web of Science ®Google Scholar
• Antoniadou A, Torres HA, Lewis RE, et al. (2003). Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore) 82:309–21
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Fuursted K, Gahrn-Hansen B, et al. (2005). Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol 43:4434–40
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Fuursted K, Gahrn-Hansen B, et al. (2008). Semi-national surveillance of fungaemia in Denmark 2004–2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect 14:487–94
   PubMed Web of Science ®Google Scholar
• Bacci A, Montagnoli C, Perruccio K, et al. (2002). Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 168:2904–13
   PubMed Web of Science ®Google Scholar
• Baltch AL, Bopp LH, Smith RP, et al. (2005). Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon γ on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages. Diagn Microbiol Infect Dis 52:299–304
   PubMed Web of Science ®Google Scholar
• Baltch AL, Bopp LH, Smith RP, et al. (2008). Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes. J Antimicrob Chemother 62:1285–90
   PubMed Web of Science ®Google Scholar
• Barros L, Alves CT, Duenas M, et al. (2013a). Characterization of phenolic compounds in wild medicinal flowers from Portugal by HPLC–DAD–ESI/MS and evaluation of antifungal properties. Ind Crops Prod 44:104–10
   Web of Science ®Google Scholar
• Barros L, Carvalho AM, Ferreira ICFR. (2010a). Leaves, flowers, immature fruits and leafy flowered stems of Malva sylvestris: a comparative study of the nutraceutical potential and composition. Food Chem Toxicol 48:1466–72
   PubMed Web of Science ®Google Scholar
• Barros L, Duenas M, Alves CT, et al. (2013b). Antifungal activity and detailed chemical characterization of Cistus ladanifer phenolic extracts. Ind Crops Prod 41:41–5
   Web of Science ®Google Scholar
• Barros L, Oliveira S, Carvalho AM, Ferreira ICFR. (2010b). In vitro antioxidant properties and characterization in nutrients and phytochemicals of six medicinal plants from the Portuguese folk medicine. Ind Crops Prod 32:572–9
   Web of Science ®Google Scholar
• Barwicz J, Dumont I, Ouellet C, Gruda I. (1998). Amphotericin B toxicity as related to the formation of oxidatively modified low-density lipoproteins. Biospectroscopy 4:135–44
   PubMedGoogle Scholar
• Bassetti M, Trecarichi EM, Righi E, et al. (2007). Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infec Dis 58:325–31
   PubMed Web of Science ®Google Scholar
• Basso FG, Oliveira CF, Fontana A, et al. (2011). In vitro effect of low-level laser therapy on typical oral microbial biofilms. Braz Dent J 22:502–10
   PubMedGoogle Scholar
• Bink A, Pellens K, Cammue BPA, Thevissen K. (2011). Anti-biofilm strategies: how to eradicate Candida biofilms? Open Mycol J 5:29–38
   Google Scholar
• Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. (2002). Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113:480–5
   PubMed Web of Science ®Google Scholar
• Blumber HM, Jarvis WR, Soucie JM, et al. (2001). Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 33:177–86
   PubMed Web of Science ®Google Scholar
• Bodasing N, Seaton RA, Shankland GS, Pithie A. (2002). Gamma-interferon treatment for resistant oropharyngeal candidiasis in an HIV-positive patient. J Antimicrob Chemother 50:765–6
   PubMed Web of Science ®Google Scholar
• Bortoletto R, Silva NS, Zângaro RA, et al. (2004). Mitochondrial membrane potential after low-power laser irradiation. Lasers Med Sci 18:204–6
   PubMed Web of Science ®Google Scholar
• Bossche HV, Willemsens G, Marichal P. (1987). Anti-Candida drugs – the biochemical basis for their activity. Crit Rev Microb 15:57–72
   PubMed Web of Science ®Google Scholar
• Bozza S, Montagnoli C, Gaziano R, et al. (2004). Dendritic cell-based vaccination against opportunistic fungi. Vaccine 22:857–64
   PubMed Web of Science ®Google Scholar
• Bozza S, Perruccio K, Montagnoli C, et al. (2003). A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102:3807–14
   PubMed Web of Science ®Google Scholar
• Brach M, Devos S, Gruss H, Herrmann F. (1992). Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920–4
   PubMed Web of Science ®Google Scholar
• Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. (1990). Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother 34:183–8
   PubMed Web of Science ®Google Scholar
• Brammer KW, Farrow PR, Faulkner JK. (1990). Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis 12:S318–26
   PubMedGoogle Scholar
• Brummer E, Hanson LH, Stevens DA. (1991). Kinetics and requirements for activation of macrophages for fungicidal activity: effect of protein synthesis inhibitors and immunosuppressants on activation and fungicidal mechanism. Cell Immunol 132:236–45
   PubMed Web of Science ®Google Scholar
• Brummer E, Morrison CJ, Stevens DA. (1985). Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun 49:724–30
   PubMed Web of Science ®Google Scholar
• Caillot D, Reny G, Solary E, et al. (1994). A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies. J Antimicrob Chemother 33:603–13
   PubMed Web of Science ®Google Scholar
• Calzavara-Pinton PG, Venturini M, Sala R. (2005). A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B 78:1–6
   PubMed Web of Science ®Google Scholar
• Carneiro VA, Santos HSD, Arruda FVS, et al. (2010). Casbane diterpene as a promising natural antimicrobial agent against biofilm-associated infections. Molecules 16:190–201
   PubMed Web of Science ®Google Scholar
• Chandra J, Kuhn DM, Mukherjee PK, et al. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183:5385–94
   PubMed Web of Science ®Google Scholar
• Cimanga K, Kambu K, Tona L, et al. (2002). Correlation between chemical composition and antibacterial activity of essential oils of some aromatic medicinal plants growing in the Democratic Republic of Congo. J Ethnopharmacol 79:213–20
   PubMed Web of Science ®Google Scholar
• Colombo AL, Nucci M, Salomão R, et al. (1999). High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagnos Microbiol Infect Dis 34:281–6
   PubMed Web of Science ®Google Scholar
• Cosentino S, Tuberoso CIG, Pisano B, et al. (1999). In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils. Lett Appl Microbiol 29:130–5
   PubMed Web of Science ®Google Scholar
• De Souza SC, Junqueira JC, Balducci I, et al. (2006). Photosensitization of different Candida species by low power laser light. J Photochem Photobiol B 83:34–8
   PubMed Web of Science ®Google Scholar
• Deray G. (2002). Amphotericin B nephrotoxicity. J Antimicrob Chemother 49:37–41
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Messer SA, Brueggemann AB, et al. (2002). Epidemiology of Candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 40:1298–302
   PubMed Web of Science ®Google Scholar
• Dignani MC, Rex JH, Chan KW, et al. (2005). Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia. Cancer 104:199–204
   PubMed Web of Science ®Google Scholar
• Doddanna SJ, Patel S, Sundarrao MA, Veerabhadrappa RS. (2013). Antimicrobial activity of plant extracts on Candida albicans: an in vitro study. Indian J Dent Res 24:401–5
   PubMedGoogle Scholar
• Donnelly RF, Mccarron PA, Tunney MM, David Woolfson A. (2007). Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J Photochem Photobiol B 86:59–69
   PubMed Web of Science ®Google Scholar
• Dorman HJD, Deans SG. (2000). Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol 88:308–16
   PubMed Web of Science ®Google Scholar
• Dougherty TJ, Gomer CJ, Henderson BW, et al. (1998). Photodynamic therapy. J Natl Cancer Inst 90:889–905
   PubMed Web of Science ®Google Scholar
• Douglas CM. (2001). Fungal beta(1,3)-D-glucan synthesis. Med Mycol 39:55–66
   PubMed Web of Science ®Google Scholar
• Duarte MCT, Figueira GM, Sartoratto A, et al. (2005). Anti-Candida activity of Brazilian medicinal plants. J Ethnopharmacol 97:305–11
   PubMed Web of Science ®Google Scholar
• Dupont BF, Lortholary O, Ostrosky-Zeichner L, et al. (2009). Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B. Crit Care 13:159
   PubMed Web of Science ®Google Scholar
• Eisenbarth SC, Colegio OR, O/'Connor W, et al. (2008). Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453:1122–6
   PubMed Web of Science ®Google Scholar
• Enoch DA, Ludlam HÁ, Brown NM. (2006). Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 55:809–18
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Canton E, Martin ME, Pemán J. (2009). Pharmacotherapy of Candida infections with echinocandins. Clin Med Insights Ther 1:889–97
   Google Scholar
• Fanning S, Mitchell AP. (2012). Fungal biofilms. PLoS Pathogens 8:1–4
   Google Scholar
• Francis P, Walsh TJ. (1992). Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. Clin Infect Dis 15:1003–18
   PubMed Web of Science ®Google Scholar
• Franzot SP, Casadevall A. (1997). Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans ins vitro. Antimicrob Agents Chemother 41:331–6
   PubMed Web of Science ®Google Scholar
• Gahn B, Schub N, Repp R, Gramatzki M. (2007). Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation. Eur J Med Res 12:337–40
   PubMed Web of Science ®Google Scholar
• Gaviria JM, Van Burik J-AH, Dale DC, et al. (1999). Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo. J Infect Dis 179:1301–4
   PubMed Web of Science ®Google Scholar
• Giroldo L, Felipe M, Oliveira M, et al. (2009). Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans. Lasers Med Sci 24:109–12
   PubMed Web of Science ®Google Scholar
• González JA, García-Barriuso M, Amich F. (2010). Ethnobotanical study of medicinal plants traditionally used in the Arribes del Duero, western Spain. J Ethnopharmacol 131:343–55
   PubMed Web of Science ®Google Scholar
• Gudlaugsson O, Gillespie S, Lee K, et al. (2003). Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172–7
   PubMed Web of Science ®Google Scholar
• Guery B, Arendrup M, Auzinger G, et al. (2009). Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intens Care Med 35:55–62
   PubMed Web of Science ®Google Scholar
• Guimarães R, Barros L, Carvalho AM, Ferreira ICFR. (2010). Studies on chemical constituents and bioactivity of Rosa micrantha: an alternative antioxidants source for food, pharmaceutical, or cosmetic applications. J Agric Food Chem 58:6277–84
   PubMed Web of Science ®Google Scholar
• Han Y, Cutler JE. (1995). Antibody response that protects against disseminated candidiasis. Infect Immun 63:2714–19
   PubMed Web of Science ®Google Scholar
• Han Y, Riesselman MH, Cutler JE. (2000). Protection against Candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect Immun 68:1649–54
   PubMed Web of Science ®Google Scholar
• Han Y, Ulrich MA, Cuttler JE. (1999). Candida albicans mannan extract – protein conjugates induce a protective immune response against experimental Candidiasis. J Infect Dis 179:1477–84
   PubMed Web of Science ®Google Scholar
• Henry KW, Nickels JT, Edlind TD. (2000). Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 44:2693–700
   PubMed Web of Science ®Google Scholar
• Hodgetts S, Nooney L, Al-Akeel R, et al. (2008). Efungumab and caspofungin: pre-clinical data supporting synergy. J Antimicrob Chemother 61:1132–9
   PubMed Web of Science ®Google Scholar
• Hübel K, Dale DC, Liles WC. (2002). Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-γ. J Infect Dis 185:1490–501
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Spellberg BJ, Avenissian V, et al. (2005). Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated Candidiasis by enhancing cell-mediated, not humoral, immunity. Infect Immun 73:999–1005
   PubMed Web of Science ®Google Scholar
• Ibrahim EH, Sherman G, Ward S, et al. (2000). The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the icu setting. Chest J 118:146–55
   PubMed Web of Science ®Google Scholar
• Jabra-Rizk MA, Falkler WA, Meiller TF. (2004). Fungal biofilms and drug resistance. Emerg Infect Dis 10:14–19
   PubMed Web of Science ®Google Scholar
• Baran J Jr, Muckatira B, Khatib R. (2001). Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Scand J Infect Dis 33:137–9
   PubMedGoogle Scholar
• Katragkou Α, Chatzimoschou A, Simitsopoulon M, et al. (2008). Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 52:357–60
   PubMed Web of Science ®Google Scholar
• Kojic EM, Darqouiche RO. (2004). Candida infections of medical devices. Clin Microbiol Rev 17:255–67
   PubMed Web of Science ®Google Scholar
• Krcméry V Jr, Kovacicová G. (2000). Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Diagn Microbiol Infect Dis 36:7–11
   PubMed Web of Science ®Google Scholar
• Ku TSN, Palanisamy SKA, Lee SA. (2010). Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals. Int J Antimicrob Agents 36:441–6
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. (2002a). Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70:878–88
   PubMed Web of Science ®Google Scholar
• Kuhn DM, George T, Chandra J, et al. (2002b). Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46:1773–80
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Oude Lashof AM, Netea MG. (2004). Design of efficacy trials of cytokines in combination with antifungal drugs. Clin Infect Dis 39:S218–23
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Netea MG, Vonk AG, Vand Der Mer JW. (1999). Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice. FEMS Immunol Med Microbiol 26:299–307
   PubMedGoogle Scholar
• Kullberg BJ, Sobel JD, Ruhnke M, et al. (2005). Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet 366:1435–42
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Verweij PE, Akova M, et al. (2011). European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect 17:1–12
   PubMed Web of Science ®Google Scholar
• Kyle AA, Dahl MV. (2004). Topical therapy for fungal infections. Am J Clin Dermatol 5:443–51
   PubMed Web of Science ®Google Scholar
• Leibundgut-Landmann S, Osorio F, Brown GD, et al. (2008). Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood 112:4971–80
   PubMed Web of Science ®Google Scholar
• Lewis RE, Kontoyiannis DP. (2001). Rationale for combination antifungal therapy. Pharmacotherapy 21:149S–64S
   PubMed Web of Science ®Google Scholar
• Lin L, Ibrahim AS, Xu X, et al. (2009). Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Phatogens 5:e1000703
   PubMed Web of Science ®Google Scholar
• Lino MD, Carvalho FB, Oliveira LR, et al. (2011). Laser phototherapy as a treatment for radiotherapy-induced oral mucositis. Braz Dent J 22:162–5
   PubMedGoogle Scholar
• Luber AD, Maa L, Lam M, Guglielmo BJ. (1999). Risk factors for amphotericin B- induced nephrotoxicity. J Antimicrob Chemother 43:267–71
   PubMed Web of Science ®Google Scholar
• Macphall GLP, Taylor GD, Buchanan-Chell M, et al. (2002). Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals. Mycoses 45:141–5
   PubMed Web of Science ®Google Scholar
• Marchetti O, Bille J, Fluckiger U, et al. (2004). Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000. Clin Infect Dis 38:311–20
   PubMed Web of Science ®Google Scholar
• Marcil A, Harcus D, Thomas DY, Whiteway M. (2002). Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment. Infect Immun 70:6319–29
   PubMed Web of Science ®Google Scholar
• Marques MM, Pereira AN, Fujihara NA, et al. (2004). Effect of low-power laser irradiation on protein synthesis and ultrastructure of human gingival fibroblasts. Lasers Surg Med 34:260–5
   PubMed Web of Science ®Google Scholar
• Martínez MJ, Betancourt J, Alonso-González N, Jauregui A. (1996). Screening of some Cuban medicinal plants for antimicrobial activity. J Ethnopharmacol 52:171–4
   PubMed Web of Science ®Google Scholar
• Mata-Haro V, Cekic C, Martin M, et al. (2007). The vaccine adjuvant monophosphoryl lipid a as a TRIF-biased agonist of TLR4. Science 316:1628–32
   PubMed Web of Science ®Google Scholar
• Matthews RC. (1994). Pathogenicity determinants of Candida albicans: potential targets for immunotherapy? Microbiology 140:1505–11
   PubMed Web of Science ®Google Scholar
• Maver-Biscanin M, Mravak-Stipetic M, Jerolimov V. (2005). Effect of low-level laser therapy on Candida albicans growth in patients with denture stomatitis. Photomed Laser Surg 23:328–32
   PubMed Web of Science ®Google Scholar
• Maver-Biscanin M, Mravak-Stipetic M, Jerolimov V, Biscanin A. (2004). Fungicidal effect of diode laser irradiation in patients with denture stomatitis. Lasers Surg Med 35:259–62
   PubMed Web of Science ®Google Scholar
• McCluskie MJ, Krieg AM. (2006). Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA. In: Pulendran B, Ahmed R, eds. From innate immunity to immunological memory. Berlin/Heidelberg: Springer
   Google Scholar
• Miceli MH, Bernardo SM, Lee SA. (2009). In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Int J Antimicrob Agents 34:326–32
   PubMed Web of Science ®Google Scholar
• Michalopoulos AS, Geroulanos S, Menitzelopoulos SD. (2003). Determinants of candidemia and candidemia-related death in cardiothoracic icu patients. Chest J 124:2244–55
   PubMed Web of Science ®Google Scholar
• Mima EGDO, Pavarina AC, Dovigo LN, et al. (2010). Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:392–401
   PubMed Web of Science ®Google Scholar
• Mora-Duarte J, Betts R, Rotstein C, et al. (2002). Comparison of Caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020–9
   PubMed Web of Science ®Google Scholar
• Moritz A, Schoop U, Goharkhay K, et al. (1998). Treatment of periodontal pockets with a diode laser. Lasers Surg Med 22:302–11
   PubMed Web of Science ®Google Scholar
• Morrell M, Fraser VJ, Kollef MH. (2005). Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640–5
   PubMed Web of Science ®Google Scholar
• Morrison VA. (2006). Echinocandin antifungals: review and update. Expert Rev Anti Infect Ther 4:325–42
   PubMedGoogle Scholar
• Munoz P, Burillo A, Bouza E. (2000). Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents 15:83–90
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. (2007). Natural products as sources of new drugs over the last 25 rears. J Nat Prod 70:461–77
   PubMed Web of Science ®Google Scholar
• Nishi I, Sunada A, Toyokawa M, et al. (2009). In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. J Infect Chemother 15:1–5
   PubMed Web of Science ®Google Scholar
• Nussbaum EL, Lilge L, Mazzulli T. (2003). Effects of low-level laser therapy (LLLT) of 810 nm upon in vitro growth of bacteria: relevance of irradiance and radiant exposure. J Clin Laser Med Surg 21:283–90
   PubMedGoogle Scholar
• Olson JA, Adler-Moore JP, Smith PJ, Proffitt RT. (2005). Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Antimicrob Agents Chemother 49:4895–902
   PubMed Web of Science ®Google Scholar
• Onishi J, Meinz M, Thompson J, et al. (2000). Discovery of novel antifungal (1,3)-β-d-glucan synthase inhibitors. Antimicrob Agents Chemother 44:368–77
   PubMed Web of Science ®Google Scholar
• Onyewu C, Heitman J. (2007). Unique applications of novel antifungal drug combinations. Anti Infect Agents Med Chem 6:3–15
   Google Scholar
• Pachl J, Svoboda P, Jacobs F, et al. (2006). A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis 42:1404–13
   PubMed Web of Science ®Google Scholar
• Pai MP. (2009). Antifungal combinations against simulated Candida albicans endocardial vegetations down-pointing small open triangle. Antimicrob Agents Chemother 53:2629–31
   PubMed Web of Science ®Google Scholar
• Pai MP, Samples ML, Mercier R-C, Splide MN. (2008). Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations. Antimicrob Agents Chemother 52:2367–76
   PubMed Web of Science ®Google Scholar
• Pai MR, Acharya LD, Udupa N. (2004). Evaluation of antiplaque activity of Azadirachta indica leaf extract gel – a 6-week clinical study. J Ethnopharmacol 90:99–103
   PubMed Web of Science ®Google Scholar
• Pappas PG, Rex JH, Lee J, et al. (2003). A prospective observational study of Candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37:634–43
   PubMed Web of Science ®Google Scholar
• Pappas PG, Rex JH, Sobel JD, et al. (2004). Guidelines for Treatment of Candidiasis. Clin Infect Dis 38:161–89
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Howard SJ, Moore CB, Denning DW. (2007). Flucytosine therapeutic monitoring: 15 years experience from the UK. J Antimicrob Chemother 59:791–3
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Boyken L, Hollis RJ, et al. (2008). In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol 46:150–6
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN, Messer SA, et al. (1998). National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 30:121–9
   PubMed Web of Science ®Google Scholar
• Pietrella D, Rachini A, Torosantucci A, et al. (2010). A β-glucan-conjugate vaccine and anti-β-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine 28:1717–25
   PubMed Web of Science ®Google Scholar
• Polonelli L, De Bernardis F, Conti S, et al. (1994). Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J Immunol 152:3175–82
   PubMed Web of Science ®Google Scholar
• Prates RA, Yamada Jr AM, Suzuki LC, et al. (2007). Bactericidal effect of malachite green and red laser on Actinobacillus actinomycetemcomitans. J Photochem Photobiol B 86:70–6
   PubMed Web of Science ®Google Scholar
• Redmond HP, Shou J, Gallagher HJ, et al. (1993). Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. J Immunol 150:3427–33
   Google Scholar
• Robinson MJ, Osorio F, Rosas M, et al. (2009). Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 206:2037–51
   PubMed Web of Science ®Google Scholar
• Rocco TR, Reinert SE, Simms H. (2000). Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance. Arch Surg 135:160–5
   PubMed Web of Science ®Google Scholar
• Romanova NA, Brovko LY, Moore L, et al. (2003). Assessment of photodynamic destruction of Escherichia coli O157:H7 and Listeria monocytogenes by using ATP bioluminescence. Appl Environ Microbiol 69:6393–8
   PubMed Web of Science ®Google Scholar
• Ruhnke M. (2006). Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets 7:495–504
   PubMed Web of Science ®Google Scholar
• Ruhnke M, Rickerts V, Cornely OA, et al. (2011). Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 54:279–310
   PubMed Web of Science ®Google Scholar
• Rüping MJ, Vehreschild JJ, Cornely OA. (2008). Patients at high risk of invasive fungal infections: when and how to treat. Drugs 68:1941–62
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Marchetti O, et al. (2003). Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 48:959–76
   PubMed Web of Science ®Google Scholar
• Saravolatz LD, Deresinski SC, Stevens DA. (2003). Caspofungin. Clin Infect Dis 36:1445–57
   PubMed Web of Science ®Google Scholar
• Sarkar S, Wilson M. (1993). Lethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis. J Periodontal Res 28:204–10
   PubMed Web of Science ®Google Scholar
• Sawaya BP, Briggs JP, Schnermann J. (1995). Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J Am Soc Nephrol 6:154–64
   PubMed Web of Science ®Google Scholar
• Schwarz F, Bieling K, Bonsmann M, et al. (2006). Nonsurgical treatment of moderate and advanced periimplantitis lesions: a controlled clinical study. Clin Oral Investig 10:279–88
   PubMed Web of Science ®Google Scholar
• Schwarz F, Sculean A, Romanos G, et al. (2005). Influence of different treatment approaches on the removal of early plaque biofilms and the viability of SAOS2 osteoblasts grown on titanium implants. Clin Oral Investig 9:111–17
   PubMed Web of Science ®Google Scholar
• Sendid B, Cotteau A, Francois N, et al. (2006). Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links. BMC Infect Dis 6:80
   PubMed Web of Science ®Google Scholar
• Sennhenn-Kirchner S, Schwarz P, Schliephake H, et al. (2009). Decontamination efficacy of erbium:yttrium–aluminium–garnet and diode laser light on oral Candida albicans isolates of a 5-day in vitro biofilm model. Lasers Med Sci 24:313–20
   PubMed Web of Science ®Google Scholar
• Shahar E, Krivoy N, Pollack S. (1999). Effective acute desensitization for immediate-type hypersensitivity to human granulocyte-monocyte colony stimulating factor. Ann Allergy Asthma Immunol 83:543–6
   PubMed Web of Science ®Google Scholar
• Shi W, Chen Z, Chen X, et al. (2010). The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. FEMS Yeast Res 10:885–93
   PubMed Web of Science ®Google Scholar
• Silva MV, Costa TR, Costa MR, et al. (2001). Growth inhibition effect of Brazilian Cerrado plant extracts on Candida species. Pharm Biol 39:138–41
   Web of Science ®Google Scholar
• Silva S, Henriques M, Martins A, et al. (2009). Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol 47:681–9
   PubMed Web of Science ®Google Scholar
• Sims CR, Ostrosky-Zeichner L, Rex JH. (2005). Invasive Candidiasis in immunocompromised hospitalized patients. Arch Med Res 36:660–71
   PubMed Web of Science ®Google Scholar
• Soukos NS, Mulholland SE, Socransky SS, Doukas AG. (2003). Photodestruction of human dental plaque bacteria: enhancement of the photodynamic effect by photomechanical waves in an oral biofilm model. Lasers Surg Med 33:161–8
   PubMed Web of Science ®Google Scholar
• Souza R, Junqueira J, Rossoni R, et al. (2010). Comparison of the photodynamic fungicidal efficacy of methylene blue, toluidine blue, malachite green and low-power laser irradiation alone against Candida albicans. Lasers Med Sci 25:385–9
   PubMed Web of Science ®Google Scholar
• Spellberg BJ, Ibrahim AS, Avanesian V, et al. (2006). Efficacy of the Anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal Candidiasis. J Infect Dis 194:256–60
   PubMed Web of Science ®Google Scholar
• Spellberg BJ, Ibrahim AS, Avanesian V, et al. (2005). The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice. Infect Immun 73:6191–3
   PubMed Web of Science ®Google Scholar
• Supreetha S, Sharadadevi M, Sequeira PS, et al. (2011). Antifungal activity of ginger extract on Candida Albicans: an in-vitro study. J Dent Sci Res 2:1–5
   Google Scholar
• Teichert MC, Jones JW, Usacheva MN, Biel MA. (2002). Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endontol 93:155–60
   PubMed Web of Science ®Google Scholar
• Tepe B, Daferera D, Sökmen M, et al. (2004). In vitro antimicrobial and antioxidant activities of the essential oils and various extracts of Thymus eigii M. Zohary et P.H. Davis. J Agric Food Chem 52:1132–7
   PubMed Web of Science ®Google Scholar
• Tobudic S, Kratzer C, Lassnigg A, et al. (2010a). In vitro activity of antifungal combinations against Candida albicans biofilms. J Antimicrob Chemother 65:271–4
   PubMed Web of Science ®Google Scholar
• Tobudic S, Lassnigg A, Kratzer C, et al. (2010b). Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. Mycoses 53:208–14
   PubMed Web of Science ®Google Scholar
• Tomás-Barberán F, Iniesta-Sanmartín E, Tomás-Lorente F, Rumbero A. (1990). Antimicrobial phenolic compounds from three Spanish Helichrysum species. Phytochemistry 29:1093–5
   Web of Science ®Google Scholar
• Torosantucci A, Bromuro C, Chiani P, et al. (2005). A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 202:597–606
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Pemam J, Bernhardt H, et al. (2004). Epidemiology of Candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23:317–22
   PubMed Web of Science ®Google Scholar
• Tramsen L, Beck O, Schuster FR, et al. (2007). Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant. J Infect Dis 196:485–92
   PubMed Web of Science ®Google Scholar
• Trick WE, Fridkin SK, Edwards JR, et al. (2002). Secular trend of hospital-acquired Candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 35:627–30
   PubMed Web of Science ®Google Scholar
• Tumvarello M, Posteraro B, Trecarichi EM, et al. (2007). Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with Candidemia. J Clin Microbiol 45:1843–50
   PubMed Web of Science ®Google Scholar
• Uppluri P, Nett J, Heitman J, Andes D. (2008). Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52:1127–32
   PubMed Web of Science ®Google Scholar
• Usacheva MN, Teichert MC, Biel MA. (2001). Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg Med 29:165–73
   PubMed Web of Science ®Google Scholar
• Van de Veerdonk FL, Netea MG, Joosten LA, et al. (2010). Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy. FEMS Microbiol Rev 34:1063–75
   PubMed Web of Science ®Google Scholar
• Van Eijk M, Van Roomen CPAA, Renkema GH, et al. (2005). Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol 17:1505–12
   PubMed Web of Science ®Google Scholar
• Vazquez JA, Gupta S, Villanueva A. (1998). Potential utility of recombinant human GM-CSF as adjunctive treatment of refractory oropharyngeal Candidiasis in AIDS patients. Eur J Clin Microbiol Infect Dis 17:781–3
   PubMed Web of Science ®Google Scholar
• Vincent J, Anaissie E, Bruining H, et al. (1998). Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24:206–16
   PubMed Web of Science ®Google Scholar
• Viscoli C, Girmenia C, Marinus A, et al. (1999). Candidemia in cancer patients: a prospective, multicenter surveillance study by the invasive fungal infection group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28:1071–9
   PubMed Web of Science ®Google Scholar
• Viviani MA. (1995). Flucytosine – what is its future? J Antimicrob Chemother 35:241–4
   PubMed Web of Science ®Google Scholar
• Wainwright M. (1998). Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 42:13–28
   PubMed Web of Science ®Google Scholar
• Wainwright M, Crossley KB. (2002). Methylene blue - a therapeutic dye for all seasons? J Chemother 14:431–43
   PubMed Web of Science ®Google Scholar
• Ward GD, Watson IA, Stewart-Tull DES, et al. (1996). Inactivation of bacteria and yeasts on agar surfaces with high power Nd: YAG laser light. Lett Appl Microbiol 23:136–40
   PubMed Web of Science ®Google Scholar
• Wenzel RP. (1995). Nosocomial Candidemia: risk factors and attributable mortality. Clin Infect Dis 20:1531–4
   PubMed Web of Science ®Google Scholar
• Wey SB, Mori M, Pfaller MA, et al. (1989). Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med 149:2349–53
   PubMed Web of Science ®Google Scholar
• White TC, Holleman S, Dy F, et al. (2002). Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46:1704–13
   PubMed Web of Science ®Google Scholar
• White TC, Marr KA, Bowden RA. (1998). Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11:382–402
   PubMed Web of Science ®Google Scholar
• Williams DW, Kuriyama T, Silva S, et al. (2011). Candida biofilms and oral candidosis: treatment and prevention. Periodontology 55:250–65
   Google Scholar
• Williams JA, Pearson GJ, Colles MJ, Wilson M. (2003). The effect of variable energy input from a novel light source on the photoactivated bactericidal action of toluidine blue O on Streptococcus Mutans. Caries Res 37:190–3
   PubMed Web of Science ®Google Scholar
• Willment JA, Lin H-H, Reid DM, et al. (2003). Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol 171:4569–73
   PubMed Web of Science ®Google Scholar
• Wilson M, Donson J, Harvey W. (1992). Sensitization of oral bacteria to killing by low-power laser radiation. Curr Microbiol 25:77–81
   PubMed Web of Science ®Google Scholar
• Wilson M, Mia N. (1993). Sensitisation of Candida albicans to killing by low-power laser light. J Oral Pathol Med 22:354–7
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, et al. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–17
   PubMed Web of Science ®Google Scholar
• Xin H, Dziadek S, Bundle DR, Cutler JE. (2008). Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci USA 105:13526–31
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Argon J, Chu J, et al. (2005). The epidemiology and attributable outcomes of Candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41:1232–9
   PubMed Web of Science ®Google Scholar
• Zhang J-D, Xu Z, Cao Y-B, et al. (2006a). Antifungal activities and action mechanisms of compounds from Tribulus terrestris L. J Ethnopharmacol 103:76–84
   PubMed Web of Science ®Google Scholar
• Zhang MX, Bohlman MC, Itatani C, et al. (2006b). Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated Candidiasis in mice. Infect Immun 74:362–9
   PubMed Web of Science ®Google Scholar